What is the clinical significance of C-reactive protein (CRP)?

Clinical Significance of C-Reactive Protein

C-reactive protein (CRP) is a sensitive but non-specific marker of systemic inflammation that has established clinical utility in cardiovascular risk stratification for intermediate-risk patients and in monitoring inflammatory conditions, though its role in sepsis diagnosis and routine pediatric screening is not supported by current evidence.

Cardiovascular Disease Risk Assessment

CRP's most evidence-based clinical application is in cardiovascular risk stratification. For patients at intermediate risk (10-20% 10-year CHD risk by Framingham), measuring high-sensitivity CRP (hsCRP) is recommended (Class IIa) to guide more aggressive risk-reduction strategies, particularly LDL-C lowering targets 1. This recommendation recognizes that elevated hsCRP can reclassify intermediate-risk patients to high-risk status, though prospective randomized trial evidence confirming clinical benefit of this strategy remains limited 1.

The mechanistic basis is well-established: CRP is implicated in endothelial dysfunction, oxidative stress, and atherosclerotic plaque destabilization 2. Recent evidence shows that both lipid-lowering agents (statins, bempedoic acid) and anti-inflammatory therapies (canakinumab, colchicine) reduce CRP levels and improve cardiovascular outcomes 2.

Important Caveats in CV Risk Assessment:

• Do not use CRP to guide treatment of acute coronary syndrome (Class III recommendation) 1
• Serial CRP measurement does not reliably reflect treatment effectiveness 1
• ACC/AHA guidelines cautiously endorse CRP for risk stratification, while European guidelines advise against routine use for primary prevention, reflecting ongoing uncertainty 2

Acute Inflammatory Conditions

CRP functions as a robust biomarker for monitoring systemic inflammatory diseases, sepsis, trauma, and malignancies 3. It is synthesized by hepatocytes in response to IL-6, IL-1, and TNF, rising rapidly within hours of tissue injury or infection 4.

Critical Limitation in Sepsis:

Recent high-quality meta-analysis (2025) demonstrates that CRP has poor diagnostic accuracy in adult sepsis, with only 56% specificity and a 44.3% false-positive rate 5. For mortality prediction in sepsis, while sensitivity is 81%, the false-positive rate remains problematic at 22.8% 5. This low specificity and high error rate severely restricts CRP's clinical utility for diagnostic or prognostic decision-making in sepsis management 5.

Respiratory Viral Infections

CRP patterns vary significantly by age and infection complexity in viral respiratory infections 6:

• Children <5 years show highest viral positivity (54%) but lowest CRP values
• CRP increases substantially with age, reaching 12.10 mg/dL in patients ≥70 years
• Co-infections (13.2%) are strongly associated with lower CRP levels 6

This supports using CRP as a supplemental marker for identifying atypical inflammatory responses, particularly in co-infections, rather than as a primary diagnostic tool 6.

Pediatric Populations

There is currently no clinical role for measuring CRP routinely in children when assessing cardiovascular risk factors 7. While numerous studies show CRP correlates with CVD risk factors and atherosclerotic progression in children, and tracks weakly from childhood to adulthood, it remains unclear whether elevated childhood CRP predicts adult CVD events 7. Lifestyle interventions decrease CRP in children, but no evidence demonstrates that lowering CRP per se modifies preclinical disease or outcomes 7.

Practical Clinical Algorithm

When to measure CRP:

1. Intermediate-risk CV patients (10-20% 10-year risk) for risk reclassification
2. Monitoring known inflammatory conditions (not for diagnosis)
3. Patients with ACS or undergoing PCI to identify those needing aggressive risk reduction
4. Supplemental marker in respiratory infections when co-infection suspected

When NOT to measure CRP:

1. Routine pediatric cardiovascular screening
2. Guiding acute coronary syndrome management
3. Primary diagnostic tool for sepsis
4. Serial monitoring of treatment response

Red flag requiring further workup:

• Persistently unexplained marked elevation (≥10 mg/L) after repeated testing warrants evaluation for non-cardiovascular causes such as infection or malignancy 1

Analytical Advantages

CRP is considered a "robust biomarker" due to relatively stable levels throughout the day and day-to-day, making it analytically reliable 7. Modern high-sensitivity assays have expanded its utility from qualitative acute inflammation detection to quantifying subclinical inflammatory processes 3.